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background:  Heart failure (HF) is associated with excess morbidity and mortality for which non-cardiac causes are increasingly recognized. We 
have previously shown an increased risk of cancer among HF patients compared with community controls. In this study, we evaluated the association 
between HF and subsequent cancer risk in a more homogeneous population of first myocardial infarction (MI) survivors.
Methods:  A prospective cohort study was conducted among Olmsted County, Minnesota, residents with incident MI from 2002-2010. After 
excluding patients with prior cancer or HF diagnosis at incident MI, 1,081 participants (mean±SD age, 64.4±15.1 years; 60% male) were followed 
for HF and cancer (excluding non-melanoma skin cancer). Time-dependent Cox regression models were fit to evaluate the hazard ratio (HR) for 
cancer risk associated with HF.
results:  During a total of 5,031 person-years of follow-up (mean±SD, 4.7±2.9 years), 101 patients developed cancer and 220 developed HF 
before cancer diagnosis. Incidence density rates for cancer diagnosis (per 1,000 person-years) were 35.3 for patients with HF and 17.2 for patients 
without HF (P<0.001). The HR for cancer associated with HF was 2.07 (95% CI: 1.34-3.20). After adjustment for age, sex, and Charlson comorbidity 
index, the HR was 1.65 (95% CI: 1.04-2.62).
conclusions:  Patients who develop HF after MI have an increased risk of cancer. This finding extends our previous report of elevated cancer risk 
after HF in general compared with controls, and calls for a better understanding of shared risk factors and underlying mechanisms.
